诊断子宫内膜癌的成本:量化异常子宫出血检查的医疗保健成本
本研究前瞻性纳入2013年2月至2017年10月单中心妇科门诊因异常子宫出血或绝经后出血就诊的≥45岁女性共1017例,从行政计费系统收集入组至入组后90天的诊疗成本并校正至2017年美元。全队列90天中位成本为2279美元,诊断为子宫内膜癌者中位成本达21039美元,结论认为诊断策略需更具成本效益。
要点
- 全队列90天中位诊疗成本为2279美元(IQR 512-4828美元)。
- 诊断为子宫内膜癌者90天中位成本为21039美元(IQR 19084-24536美元)。
- 良性或增生紊乱性子宫内膜诊断者中位成本为2203美元(IQR 499-3604美元)。
核心结论
- 围绝经期异常子宫出血和绝经后出血的诊断评估成本随最终组织学诊断不同而差异很大,即使是不需进一步干预的良性结果也产生可观成本,作者认为需要开发敏感、特异且更具成本效益的诊断策略。
研究设计与样本
- 前瞻性研究,纳入2013年2月至2017年10月在单中心妇科门诊因异常子宫出血或绝经后出血接受诊断检查的≥45岁女性共1017例,诊疗方案由各接诊医生自行决定,成本来自行政计费系统并校正至2017年美元。
主要发现
- 全队列1017例中5.6%诊断为不典型增生或子宫内膜癌。
- 全队列90天中位诊疗成本为2279美元(IQR 512-4828美元)。
- 接受诊断性活检者中,良性或增生紊乱性子宫内膜诊断的90天中位成本为2203美元(IQR 499-3604美元),子宫内膜癌诊断为21039美元(IQR 19084-24536美元)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The evaluation of women with perimenopausal abnormal uterine bleeding (AUB) and postmenopausal bleeding (PMB) to detect endometrial cancer (EC) and its precursors is not standardized and can vary widely. Consequently, costs associated with the workup and management undoubtedly vary. This study aimed to quantify costs of AUB/PMB evaluation to understand the healthcare burden associated with securing a pathologic diagnosis. METHODS: Women ≥45 years of age presenting to a single institution gynecology clinic with AUB/PMB for diagnostic workup were prospectively enrolled February 2013-October 2017 for a lower genital tract biospecimen research study. Clinical workup of AUB/PMB was determined by individual provider discretion. Costs of care were collected from administrative billing systems from enrollment to 90 days post enrollment. Costs were standardized and inflation-adjusted to 2017 US Dollars (USD). RESULTS: In total, there were 1017 women enrolled with 5.6% diagnosed with atypical hyperplasia or endometrial cancer (EC). Within the full cohort, 90-day median cost for AUB/PMB workup and management was $2279 (IQR $512-4828). Among patients with a diagnostic biopsy, median 90-day costs ranged from $2203 (IQR $499-3604) for benign or disordered proliferative endometrium (DPE) diagnosis to $21,039 (IQR $19,084-24,536) for a diagnosis of EC. CONCLUSIONS: The costs for diagnostic evaluation of perimenopausal AUB and PMB vary greatly according to ultimate tissue-based diagnosis. Even reassuring benign findings that do not require further intervention-the most common in this study's cohort-yield substantial costs. The development of sensitive, specific, and more cost-effective diagnostic strategies is warranted.
引用
- Warring SK, Borah B, Moriarty J, et al. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup. Gynecol Oncol. 2021. PMID: 34756471. doi:10.1016/j.ygyno.2021.10.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。